Vivelle dot Forðaplástur 100 míkróg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

vivelle dot forðaplástur 100 míkróg

sandoz a/s - estradiolum inn - forðaplástur - 100 míkróg

Vivelle dot Forðaplástur 25 míkróg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

vivelle dot forðaplástur 25 míkróg

sandoz a/s - estradiolum inn - forðaplástur - 25 míkróg

Vivelle dot Forðaplástur 37,5 míkróg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

vivelle dot forðaplástur 37,5 míkróg

sandoz a/s - estradiolum inn - forðaplástur - 37,5 míkróg

Vivelle dot Forðaplástur 50 míkróg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

vivelle dot forðaplástur 50 míkróg

sandoz a/s - estradiolum inn - forðaplástur - 50 míkróg

Vivelle dot Forðaplástur 75 míkróg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

vivelle dot forðaplástur 75 míkróg

sandoz a/s - estradiolum inn - forðaplástur - 75 míkróg

Rewellfem Leggangatafla 10 míkróg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

rewellfem leggangatafla 10 míkróg

gedeon richter plc.* - estradiolum inn - leggangatafla - 10 míkróg

Depo-Provera Stungulyf, dreifa 50 mg/ml Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

depo-provera stungulyf, dreifa 50 mg/ml

pfizer aps - medroxyprogesteronum acetat - stungulyf, dreifa - 50 mg/ml

Femanest Tafla 1 mg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

femanest tafla 1 mg

viatris aps - estradiol - tafla - 1 mg

Femanest Tafla 2 mg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

femanest tafla 2 mg

viatris aps - estradiol - tafla - 2 mg

Senshio Euroopan unioni - islanti - EMA (European Medicines Agency)

senshio

shionogi b.v. - ospemifene - postmenopause - hormón kynlíf og stillum kynfæri - senshio is indicated for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy (vva) in post-menopausal women.